Prosecution Insights
Last updated: July 17, 2026
Application No. 18/280,081

DIELECTRIC MATERIALS BASED ON AMIDE-IMIDE-EXTENDED BISMALEIMIDES

Non-Final OA §103
Filed
Sep 01, 2023
Priority
Mar 04, 2021 — EU 21160642.1 +1 more
Examiner
DU, SURBHI M
Art Unit
1765
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Merck Patent GmbH
OA Round
1 (Non-Final)
68%
Grant Probability
Favorable
1-2
OA Rounds
3m
Est. Remaining
95%
With Interview

Examiner Intelligence

Grants 68% — above average
68%
Career Allowance Rate
79 granted / 117 resolved
+2.5% vs TC avg
Strong +28% interview lift
Without
With
+27.8%
Interview Lift
resolved cases with interview
Typical timeline
3y 2m
Avg Prosecution
35 currently pending
Career history
157
Total Applications
across all art units

Statute-Specific Performance

§103
79.3%
+39.3% vs TC avg
§102
5.3%
-34.7% vs TC avg
§112
6.4%
-33.6% vs TC avg
Black line = Tech Center average estimate • Based on career data from 117 resolved cases

Office Action

§103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Election/Restrictions Applicant's election with traverse of claims 1, 3-5 and 7-12 (claims 2 and 6 are cancelled) in the reply filed on 05/26/2026 is acknowledged. The traversal is on the ground(s) that Gupta et al. does not teach the amended claim structure. This is found to be not persuasive because, although Gupta no longer anticipates the amended claim structures, as discussed in the rejection below the combination of Gupta and Nakai render the bismaleimide compound obvious, and therefore the common technical feature “a bismaleimide compound” shared by Groups I, II and III fails to constitute a special technical feature over the prior art. The limitations set forth in the claims fail to define a contribution over the combination of Gupta and Nakai. In response to applicant’s argument that the patent office has not established that it would pose an undue burden to examine the full scope of the claims, since the instant application is filed under national stage 35 U.S.C. 371 (unity of invention analysis) as compared to national applications filed under 35 U.S.C. 111(a) (independent and distinct analysis), the restriction is proper and the establishment of undue examination burden is not needed. The requirement is still deemed proper and is therefore made FINAL. Claims 13-17 and 19-20 are withdrawn from further consideration pursuant to 37 CFR 1.142(b), as being drawn to a nonelected claims, there being no allowable generic or linking claim. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. Claims 1, 3-5 and 7-12 are rejected under 35 U.S.C. 103 as being unpatentable over Gupta et al. Addition Polyamide-Imides based on Itaconic Anhydride, Journal of Polymer Science: Part A:Polymer Chemistry 1990, Vol 28, pages 935-943, and in view of Nakai et al. JP-2020012104-A. Regarding claims 1, 4-5 and 12, Gupta teaches polyamide-imide resin and recommends the inclusion of amide linkages within the polyimide backbone to make the polymer more soluble, moldable and processable (Introduction). Gupta teaches a bismaleimide compound with amide linkages (in precursor 2, scheme 4) via formation of intermediate N, N'-bis(4-carboxyphenyl)pyromellitimide where 4-aminobenzoic acid (scheme 2) is utilized as the aromatic amino acid. Gupta does not discuss the use of aliphatic amino acids as possible reactants to derive the amide (and imide) linkages. Analogous reference Nakai who also teaches polyamide-imide polymers, teaches aliphatic amino acid such as beta-alanine which is noted as equivalent to 4-aminobenzoic acid, where the use of aliphatic amino acid is encouraged to improve solubility and minimize the color formation in the final polyamide-imide (Nakai paras 66 and 67). Since it is prima facie obvious to substitute art recognized equivalents for the same purpose (MPEP 2144.06 II), it would have been obvious to one of ordinary skilled in the art before the effective filing date of the invention to have modified Gupta with beta-alanine as the amino acid as the reactant to create the amide repeat unit (and imide) to improve solubility and decrease possible color formation in the final bismaleimide based polyamide-imide. Utilization of beta-alanine instead of 4-amino benzoic acid in Gupta’s structure precursor 2 would result in structure as depicted below. PNG media_image1.png 354 1256 media_image1.png Greyscale Which reads on structural Formula 3b with n=1, where Ra and Rb are a combination of aromatic and aliphatic moieties, X is an unsubstituted aliphatic moiety with 2 carbon atoms (instant claims 4 and 12), and R1 is H and R2 is methyl group. Regarding claim 3, Gupta utilizes 4,4'-diaminodiphenylmethane (scheme 1) as the diamine. A methyl ring substitution on phenyl rings to generate 4,4'-diamino -3,3’-dimethyldiphenylmethane would be readily envisaged by a person having ordinary skill in the art, to further tune the solubility and hydrophobicity of the polyimide-amide structure. See MPEP2131.02.I. and III. 4,4'-diamino -3,3’-dimethyldiphenylmethane meets the claimed structure of Ra and Rb which are a combination of substituted aromatic moieties having total 12 carbon atoms (from diphenyl), along with aliphatic moieties having 3 carbon atoms. Regarding claims 7 and 8 which relate to alternatives, the combination of Gupta and Nakai render the alternate requirement of 3b obvious. Regarding claims 9-11, Gupta utilizes 4,4'-diaminodiphenylmethane (scheme 1) as the diamine corresponding to Ra and Rb, as discussed when addressing claims 1 and 3. Gupta is silent on the use of an aliphatic diamine, but secondary reference Nakai teaches (para [0049]) the use of dimer diamine Priamine-1075 ® Croda, in order to tailor the final use of the polyamide-imide. Priamine-1075 ® corresponds to Formula (8a) (and Formula (7a)), and is also utilized by the instant specification (page 52, line 21). Nakai adds that the use of aliphatic diamines such as dimer diamine enhances the non-color forming property of the final polyamide-imide (para [0052]). It would have been obvious to one of ordinary skilled in the art before the effective filing date of the invention to have modified Gupta with dimer diamine Priamine-1075 ® as the diamine reactant to generate the imide-amine repeat units for the same application of creating a bismaleimide based polyamide-imide with reduced color. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to Surbhi M Du whose telephone number is (571)272-9960. The examiner can normally be reached M-F 9:00 am to 5:00pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Heidi (Riviere) Kelley can be reached at 571-270-1831. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /S.M.D./ Examiner Art Unit 1765 /JOHN M COONEY/Primary Examiner, Art Unit 1765
Read full office action

Prosecution Timeline

Sep 01, 2023
Application Filed
Jun 26, 2026
Non-Final Rejection mailed — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12679961
FILLED AUTOMOTIVE POLYPROPYLENE COMPOSITION CONTAINING RECYCLATES
3y 5m to grant Granted Jul 14, 2026
Patent 12674033
POLYCARBONATE-POLYORGANOSILOXANE COPOLYMER
4y 0m to grant Granted Jul 07, 2026
Patent 12674055
PHLOROGLUCINOLIC RESINS, METHODS OF MAKING, AND USES IN RUBBER COMPOSITIONS
4y 0m to grant Granted Jul 07, 2026
Patent 12648579
MEDIUM-CHAIN-LENGTH POLYHYDROXYALKANOATES AND THEIR USE IN CHEWING GUM BASES
4y 1m to grant Granted Jun 09, 2026
Patent 12624162
POLYCARBONATE COPOLYMER
2y 11m to grant Granted May 12, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
68%
Grant Probability
95%
With Interview (+27.8%)
3y 2m (~3m remaining)
Median Time to Grant
Low
PTA Risk
Based on 117 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month